Single-agent bevacizumab is an effective treatment in recurrent glioblastoma
Crossref DOI link: https://doi.org/10.1007/s12032-014-0460-3
Published Online: 2015-01-09
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hacibekiroglu, Ilhan
Kodaz, Hilmi
Erdogan, Bulent
Turkmen, Esma
Ozcelik, Melike
Esenkaya, Asim
Saygi, Haci Mehmet
Uzunoglu, Sernaz
Cicin, Irfan
Text and Data Mining valid from 2015-01-09